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Abstract
Summary This pilot study in women from The Gambia with
low habitual calcium intakes showed differences in calcio-
tropic hormones between pregnant, lactating and non-
pregnant, non-lactating women similar to those in Western
women. The response to oral calcium loading indicates a
high degree of calcium conservation independent of repro-
ductive status.
Introduction In pregnancy and early lactation, parathyroid
hormone (PTH) concentrations may be suppressed. Uncer-
tainty exists about how calcium metabolism is regulated,
particularly when calcium intake is low.
Methods We investigated fasting markers of calcium metab-
olism and the acute calcemic and calciuric responses after an
oral calcium load in 30 pregnant, lactating or non-pregnant,
non-lactating (NPNL) Gambian women with low habitual
calcium intakes. Women received 1 g elemental calcium
(CaCO3) at 0 min. Blood was collected at −30 and 180 min.
Urine was collected from −60 to 0, 0–120 and 120–240 min.
Samples were analysed (blood: ionized calcium (iCa); plasma
(p): total calcium (tCa), phosphate (P), creatinine (Cr), PTH,
1,25-dihydroxyvitamin D (1,25(OH)2D), osteocalcin (OC), β
C-terminal cross-linked telopeptide of type 1 collagen
(βCTX), cyclic adenosine monophosphate (cAMP); urine
(u): Ca, P, Cr, cAMP).
Results Pre-loading, groups did not differ significantly in
iCa, pP, uCa/Cr and uP/Cr. pOC concentrations were signif-
icantly lower and NcAMP and p1,25(OH)2D higher in preg-
nant women; pPTH and pβCTX in lactating women were
higher than in NPNL women. Post-loading, iCa, ptCa and
uCa/Cr concentrations increased; pPTH, NcAMP, βCTX
and uP/Cr decreased in all groups, but the magnitude of
change did not differ significantly between groups.
Conclusion Differences between pregnant, lactating and
NPNL Gambian women in pPTH, NcAMP and p1,25(OH)2D
and bone markers were similar to Western women. How-
ever, the response to calcium loading indicates that there
may be no differences in renal and intestinal calcium
economy associated with reproductive status, potentially
due to a high degree of calcium conservation associated
with low intakes.
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Introduction
Adaptations in maternal calcium homeostasis and balance
occur during late pregnancy and lactation to meet require-
ments for foetal bone mineralisation and calcium secretion
into breast milk. In Western women, intestinal calcium
absorption increases in pregnancy [1–3]. Little change in
the maternal bone mineral status (bone mineral density or
content) is observed, although an increase in bone remodel-
ling is reported [3, 4]. During lactation, bone resorption and
renal calcium conservation are increased in both Western
and Gambian women with concomitant decreases in bone
mineral status [1, 5–7]. Changes in maternal bone mineral
status and bone resorption during pregnancy and lactation
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appear to be independent of calcium intake in populations
with a wide range of habitual calcium intakes [3, 4].
Uncertainty exists about how maternal calcium metabo-
lism and balance are regulated, particularly in women with
very low calcium intakes. During pregnancy and early lac-
tation, plasma PTH concentration (pPTH) is suppressed, but
plasma 1,25-dihydroxyvitamin D (p1,25(OH)2D) is similar
or elevated compared to non-pregnant, non-lactating women
(NPNL) [3, 8, 9]. This may be explained partly by the
increase in the plasma concentration of PTH-related peptide
(PTHrP). The role of PTHrP in the regulation of maternal
calcium and bone metabolism is unclear, however, as it does
not appear to respond to changes in plasma calcium [2, 4,
10], unlike PTH which remains responsive to changes in
calcium metabolism during pregnancy and lactation despite
its lower concentration [1, 11]. Earlier studies in Australia
and USA applied calcium-loading (or oral calcium-
tolerance) tests to investigate changes in calcium homeosta-
sis in pregnant and lactating women with calcium intakes
close to recommendations [1, 2]. The calcium-loading test
utilizes a single oral dose of calcium and is designed to test
the response of the calciotropic hormones and calcium han-
dling in the intestine and kidney to provide a proxy measure
of the rate of calcium absorption and renal calcium excretion
[2, 12]. In this pilot study, we investigated the calcemic and
calciuric responses to oral calcium loading in pregnant,
lactating and NPNL rural Gambian women with a habitual
calcium intake of ~350 mg/day. We aimed to provide pilot
data to investigate adaptations in calcium homeostasis dur-
ing the reproductive cycle in Gambian women and to inves-
tigate that there was an indication of the pattern of response
to be different from women with a higher calcium intake in
order to consider whether a larger study is warranted.
Materials and methods
Subjects
Healthy pregnant, lactating and non-pregnant, non-lactating
(NPNL) women, ten in each group, were identified through
the West Kiang database and were recruited in 2008 from
the villages of Keneba, Manduar and Kanton Kunda, in
West Kiang, The Gambia, West Africa. Subjects were
matched for age and parity at inclusion. Trained field-
workers explained the study in the participant’s native lan-
guage, and an informed written consent was obtained.
Pregnant women were 30–36 weeks gestation, based on
predicted date of delivery as estimated by a midwife after
an ultrasound scan and the date of the last menstrual period,
and was back tracked on the basis of the date of birth of the
baby. Lactating women were 2–4 months post-partum based
on the date of birth of their child and were demand
breastfeeding. NPNL women reported to have recently had
their menstrual period and were at least 3 months post-
lactation; the period of breastfeeding in this region is typi-
cally 18–24 months [7]. We did not collect information on
the use of contraceptives as this is a sensitive issue in this
community and would have been unlikely to result in accu-
rate data. The study took place at the MRC Keneba Field-
station in the wet season (June–September). The study was
approved by the joint Gambian Government/MRC Ethics
Committee, and the London School of Hygiene and Tropical
Medicine Ethics Committee.
Calcium-loading test
The strictly standardized protocol was based on that used in
pregnant, lactating and NPNL white Australian women by
Kent et al. [1]. Women arrived between 0700 and 0800 hours
after an overnight fast and were asked to empty their bladder
60 min prior to being given the calcium dose. This consisted
of 1 g elemental calcium (given as two CaCO3 tablets;
Calcichew, Shire Pharmaceuticals Ltd., UK). Water
(200 ml) was given every hour. Blood samples were taken
30 min before (pre-Ca) and 180 min after the calcium (post-
Ca) dose. All urine produced between 60 min pre-Ca and
baseline and from baseline to 120 and 240 min post-Ca was
collected. All samples were collected within 5 min before or
after the scheduled time). A small standardized meal (300 g
of porridge, composed of 49 g millet flour, 230 ml water, 1 g
salt, 20 g sugar; composition: 780 kJ, 14 mg calcium, 36 mg
phosphorus, 0.1 mg phytates) was given 30 min post-Ca,
and participants were requested to eat it all.
Sample collections and laboratory analyses
Blood samples were collected into pre-cooled lithium–hep-
arin (LH) or EDTA tubes (S-Monovette, Sarstedt Ltd,
Leicester, UK). The EDTA sample was placed on ice im-
mediately. The LH whole blood sample was measured for
ionized calcium (iCa; pH 7.4 corrected values), haemoglo-
bin (Hb) and pH within 10 min of collection (ABL77 blood
gas analyser, Radiometer, Brønshøj, Denmark), and the
remaining sample was then placed on ice. Plasma was
separated within 1 h of collection in a refrigerated centrifuge
at 1,800 g for 20 min, and aliquots were stored at −70 °C.
Urine was collected in acid-washed containers, mixed
thoroughly. Non-acidified and acidified (concentrated
hydrochloric acid (HCl), 10 ml/l, laboratory reagent grade,
SG 1.18, Fisher Scientific) aliquots were taken and stored
at −20 °C.
After completion of the study, plasma and urine
samples were packed and shipped on dry ice to MRC
Human Nutrition Research, Cambridge and subsequently
stored at −80 °C until analysis.
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LH plasma was used for the measurement of
1,25(OH)2D (radioimmunoassay IDS Ltd., Tyne and
Wear, UK), 25-hydroxyvitamin D (25(OH)D), bone-
specific alkaline phosphatase (BALP), osteocalcin (OC)
(all chemiluminescent immunometric automated assays,
CLIA; DiaSorin, Stillwater, MN, USA), β C-terminal
cross-linked telopeptide of type 1 collagen (βCTX)
(ELISA, IDS Ltd., Tyne & Wear, UK), cAMP (ELISA,
R&D Systems, Abington, UK), total calcium (tCa),
phosphate (P), creatinine (Cr) and albumin (Alb) (color-
imetric methods, Kone Lab 20i clinical chemistry ana-
lyser platform, Kone Espoo, Finland). EDTA plasma
was used for the measurement of PTH by immunoassay
(Immulite, Siemens Healthcare Diagnostics Ltd, Cam-
berley, UK).
Urinary (u) calcium (uCa), phosphate (uP) and creatinine
(uCr) were measured in acidified urine (colorimetric meth-
ods, Kone Lab 20i, as above). Concentrations of uCa and uP
were expressed as a ratio relative to uCr to adjust for urinary
volume. Urinary cAMP was measured in non-acidified urine
(ELISA, R&D Systems, as above).
All assays except PTH (between-assay coefficient of
variation (CV), 4.7 %) were performed in duplicate. As-
say performance was monitored using kit and in-house
controls and under strict standardisation according to
ISO 9001:2000. Quality assurance of 25(OH)D and
1,25(OH)2D assays were performed as part of the Vitamin
D External Quality Assessment Scheme (www.deqas.org)
and PTH assays as part of the National External Quality
Assessment Scheme (www.ukneqas.org.uk), and all were
within accepted limits.
Within- and between-assay CVs for 1,25(OH)2D were
7.5 and 9.0 %. Cross-reactivity of the assay is 100 and
91 % for 1,25(OH)2D3 and 1,25(OH)2D2, respectively.
Cross-reactivity of the 25(OH)D assay is 100 and 104 %
for 25(OH)D3 and 25(OH)D2, respectively. Within- and
between-assay CVs were 3.7 and 2.9, 1.6 and 3.6, and 3.8
and 4.0 % for 25(OH)D, BALP and OC, respectively. The
within- and between-assay CVs for βCTX were 2.9 and
1.4 %. Within- and between-assay CVs for all Kone assays
were <2 and <4 %, respectively. Within- and between-assay
CVs for pcAMP and ucAMP were 6.0 and 4.8 %.
Statistics, data handling and derived variables
Data processing and statistics were performed using Micro-
soft Excel 2010 (Microsoft Corp., Seattle, WA, USA) and
Linear Model Software in Data Desk 6.0 (Data Description,
Inc., Ithaca, NY, USA). Non-normally distributed data were
transformed to natural logs. Within- and between-group
differences were analysed with ANOVA or ANCOVA as
appropriate, with Scheffé post-hoc tests. The absolute
change in each analyte was examined to investigate the
response to calcium loading. The level of significance was
set at P≤0.05. Because of the small numbers of participants,
P values ≤0.10 are also reported to indicate possible trends
in the data.
The following variables were derived:
Albumin-corrected calcium (pCaAlb =ptCa + [(40−Alb
(g/L))×0.02]) [13, 14].
The fract ional excre t ion of calc ium (Cae =
(uCa/uCr)×pCr) and of P (Pe = (uP/uCr)×pCr) [2].
Nephrogenic cAMP (NcAMP = (ucAMP − pcAMP) ×
(pCr/uCr)) [14]
The renal calcium threshold (TmCa/GFR = [(0.56×
pCa)−Cae]/[1−0.08loge(0.56×pCa)/Cae)]).
The renal threshold for phosphate (TmP/GFR) =
TRP×pP, if TRP≤0.86. If TRP>0.86, TmP/GFR=α×
pP. TRP= 1 – [(uP/pP) × (pCr/uCr)] and α=0.3 ×
TRP/[1–(0.8×TRP)] as described by Payne [15].
For the calculation of albumin-corrected calcium, dif-
ferent equations [13, 16, 17] and group-specific equa-
tions, as based on regression analyses, were used
because the albumin–calcium relationships may differ
between populations and reproductive stages. Bland–Alt-
man analyses [18] showed no significant differences
between the values calculated according to different
methods. Further, regression analyses of the calcium–
albumin relationship showed no significant group inter-
action (P=0.4). Therefore, the Payne equation [13, 16]
was used for further analyses. The dataset contained one
outlier in Cae in the pregnant group as detected by
standard procedures (Data Desk 6.0), and this value
was excluded from analyses, but its inclusion made no
material difference to the conclusions drawn.
We aimed to be able to detect a difference of 1.5 SD
between groups with a sample size of n=10 per group.
A formal power calculation could not be performed for
this study as the mean and distribution of most of the
measured biochemical parameters are known to be
markedly different from those in Western populations,
and no data for the response to calcium loading are
available in this population.
Results
Subject characteristics and baseline data
Subject characteristics are given in Table 1. Age, height,
parity and weight were not significantly different between
groups. Concentrations of pAlb, pCr, Hb and ptCa were
significantly lower in pregnant women than in lactating
and NPNL women. There were no significant group differ-
ences in ptCa when corrected for pAlb, or in p25(OH)D,
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iCa, pP, uCa/Cr, uP/Cr, TmCa/GFR, TmP/GFR, Cae and Pe
(Table 1; Figs. 1–3). The p1,25(OH)2D concentration was
significantly higher and pOC and BALP (tendency) lower in
pregnant than in lactating and NPNL women. In pregnant
women, pPTH was lower compared to lactating women, and
NcAMP was higher than in NPNL women. In lactating
women, pPTH, p1,25(OH)2D and pβCTX concentrations
were or tended to be (P≤0.1) higher than in NPNL women
(Table 1; Figs. 1–3).
There was a consistent pattern of uCa/Cr, Cae and Pe to
be lower in pregnant and lactating than in NPNL and of pP,
uP/Cr and TmP/GFR to be higher in pregnant women,
although this did not reach statistical significance.
Post-Ca loading
Concentrations of iCa and ptCa significantly increased
and pPTH, NcAMP and pβCTX decreased in all groups
(Figs. 1–3). Only in pregnant women was there a sig-
nificant decrease in pP and an increase in p1,25(OH)2D.
In lactating women, pOC decreased. No differences
were found in the plasma concentration of BAP possi-
bly due to its long half-life. In all groups, uCa/Cr
significantly increased and uP/Cr decreased from 120
to 240 min post-loading. This was paralleled by a
significant increase in TmP/GFR and decrease in Pe in
all groups. TmCa/GFR decreased and Cae increased
only in pregnant women. The magnitude of change did
not differ significantly between groups for any of the
analytes in blood and urine.
Relationships between the increases in ptCaAlb and in
Cae and pP and Pe are shown in Fig. 2c, d. Significant
increases in Cae per unit of ptCaAlb were found in pregnant
women only. Significant decreases in Pe per unit of pP were
found in all groups.
Discussion
This pilot study showed that in pregnant Gambian women
with a low calcium intake, NcAMP and p1,25(OH)2D were
higher, and bone formation was lower than in NPNL wom-
en. There was no evidence for pregnancy-induced absorp-
tive hypercalciuria. In lactating women, pPTH and bone
resorption were higher and p1,25(OH)2D tended to be
higher. Pregnant, lactating and NPNL women responded in
a similar way and to a similar extent to calcium loading.
This may indicate that pregnant, lactating and NPNL wom-
en from The Gambia may have similar rates of intestinal
calcium absorption and extent of renal calcium conserva-
tion. The physiological changes in calcium and bone me-
tabolism occurring in pregnancy and lactation may not lead
to increases in calcium conservation.
These findings differ from those reported in pregnant and
lactating women with calcium intakes close to Western
recommendations [1, 2]. Those studies showed a greater
Table 1 Subject characteristics and baseline values of markers of calcium, phosphate and bone metabolism
Pregnant Lactating Non-pregnant, non-lactating
n=10 n=10 n=10
Subject characteristics
Age (years) 29.7±2.2 27.3±2.0 27.6±2.2
Weight (kg) 62.5±3.6 59.4±2.8 55.8±2.4
Height (m) 1.62±0.02 1.65±0.01 1.59±0.02
Parity 4.6±0.8 (1–8)1 3.6±0.78 (1–7)1 3.0±0.9 (0–7)1
Gestation/post-partum (weeks) 32.6±0.5 14.2±0.20 −
pCr(mmol/L) 59.2±1.5NL 70.3±2.9 74.0±2.5
pAlb (g/L) 25.5±0.8NL 36.7±0.91 34.1±0.65
Hb (g/L) 11.2±0.38NL 13.2±0.57 13.0±0.35
p25(OH)D (nmol/L) 59.7±3.8 63.2±5.1 70.4±4.6
Markers of renal mineral handling
TmCa/GFR (mmol/L GFR) 2.31±0.20 2.39±0.15 2.15±0.15
TmP/GFR (mmol/L GFR) 1.25±0.06 1.42±0.08 1.18±0.09
Values are given as mean ± SE or when indicated1 as range (min–max)
Cr creatinine, Hb haemoglobin, 25(OH)D 25(OH) vitamin D, p plasma, TmCa/GFR the renal calcium threshold, TmP/GFR the renal threshold for
phosphate
Letters are used to indicate
significant between-group differences in baseline values as tested by ANOVA/Scheffé (P ≤ 0.05); N significantly different to
non-pregnant and non-lactating women; L significantly different to lactating women
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response in ptCa, iCa and urinary calcium excretion in
pregnant women, whereas lactating women showed a lower
post-loading calcium excretion. These responses are indica-
tive of an up-regulation of intestinal calcium absorption and
renal reabsorption of calcium, respectively [2, 12]. Howev-
er, further studies specifically designed to assess calcium
economy in the intestine and kidney are needed to confirm
these findings.
The differences in the response to calcium loading and
results of our previous studies of pregnant and lactating
women from The Gambia may indicate that the adaptations
in calcium homeostasis may be different for Western and
Gambian women. On theoretical grounds and as shown in
our earlier studies in this population [19], it may be expected
that with a calcium intake of ~350 mg/day, calcium absorp-
tion and renal calcium reabsorption are near their physio-
logical maximum to meet the requirements for obligatory
calcium losses in urine and faeces and, additionally during
the reproductive cycle, for foetal skeletal mineralisation,
secretion into breast milk (~200–300 mg/day) and post-
Fig. 1 Baseline (black) and response (grey) of total plasma calcium
(Ca; a), ionized Ca (b), phosphate (P; c), parathyroid hormone (PTH;
d), nephrogenic cAMP (NcAMP; e) and 1,25-dihydroxy vitamin D
(1,25(OH)2D; f) to calcium loading in pregnant, lactating and non-
pregnant and non-lactating women. Data are presented as mean + SE.
Asterisk is used to indicate significant within-group differences com-
pared to baseline as tested with paired t tests. Letters are used to
indicate significant between-group differences in baseline values as
tested by ANOVA/Scheffé (P≤0.05); N significantly different to non-
pregnant and non-lactating women; L significantly different to lactat-
ing women. Circumflex accent tendency to be significantly different as
tested by ANOVA/Scheffé (P≤0.10); No significant between-group
differences in the change of any of these analytes were found
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lactational maternal bone mineral accretion [3]. This is
underpinned by the low urinary calcium losses in Gambian
NPNL and pregnant women shown in this study and other
studies in this population [7], and by the absence of or only
a moderate decrease in, urinary calcium losses during lacta-
tion as measured in 24 h, fasting and post-loading urine
collections (this study; [7]).
An alternative explanation for the absence of differences
in the calcemic response between reproductive stages is the
length of lactation (up to 2 years) and the typically short
interval between cessation of lactation and next conception
in this population [7]. The NPNL women in this study may
therefore be in a different physiological state than those
women included in other reports [1, 2] and may have a
greater or more prolonged rate of calcium incorporation into
the maternal skeleton in response to cessation of lactation.
The three groups were matched for age and parity, and the
NPNL women were eumenhorreic. It is, therefore, unlikely
that the findings of the study reflect biological differences in
the ability to conceive.
Despite the apparent moderate differences in calcium
homeostasis between pregnant and lactating Gambian wom-
en compared to the differences seen in Western women, our
earlier studies have shown that the changes in bone mineral
status in lactating Gambian mothers at 13 weeks post-
partum are similar to those reported for breastfeeding moth-
ers with higher calcium intakes [5, 7]. This is consistent with
other findings that dietary calcium intake is not a predictor
of the changes in maternal bone mineral status associated
with lactation [3, 4]. The conservation of bone mineral may
be partly explained by the lower calcium outputs in breast
milk, as mean milk calcium concentrations from Gambian
women are lower than those of British women [7, 20, 21].
Together with a high degree of renal calcium conservation
during both pregnancy and lactation, a decrease in bone
formation during pregnancy and an increase in bone resorp-
tion during lactation [5, 7], these adaptations may be suffi-
cient to meet the calcium requirements for foetal skeletal





































Fig. 2 Response in renal excretion of calcium (urine Ca; a) and
phosphate (urine P; b) expressed as a ratio to urinary creatinine (Cr)
to Ca loading in pregnant, lactating and non-pregnant and non-lactating
women. Relationships between the response in albumin-corrected plas-
ma calcium (ptCaAlb) and fractional Ca excretion (Cae) and plasma P
(pP) and fractional P excretion (Pe) are shown in c and d. Symbols are
used to indicate pregnant (black square), lactating (black triangle) and
non-pregnant and non-lactating women (black diamond). Asterisk is
used to indicate significant within-group differences compared to base-
line (pre-Ca) and cross compared to 120 min post-Ca as tested with
paired t-tests. Data are presented in mean + SE. No significant be-
tween-group differences in the change of any of these analytes were
found. Further explanations of symbols and abbreviations used are
described in Fig. 1
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In all groups, plasma PTH was relatively high. This is a
common finding in this population and is likely to be due to
their low calcium and high phytate intake [7, 17, 22]. In
parallel to findings in Western women, NcAMP was
relatively high for its concurrent plasma PTH concentration
in pregnant Gambian women, but both did respond signifi-
cantly to an acute calcium load. This suggests that, as in
Western women, the parathyroid gland in Gambian women
adapted to a low calcium intake is responsive to change in
plasma calcium, but that other regulatory factors such as
PTHrP are involved in calcium and phosphate metabolism
during pregnancy.
There are several limitations of this study. Firstly, it in-
cluded only ten women per group, and calcium-loading tests
were performed on a cross-sectional basis. This will have
limited the power of the statistical analyses and conclusions
about changes that might be expected within individuals. In
addition, during pregnancy, expansion of the plasma volume
may have confounded the observed response particularly of
plasma calcium in this and previous studies. This may only
partly be corrected for by the use of ptCaAlb.
Comparability to the work by Gertner et al. [2] and
Kent et al. [1] may be limited due to small differences
between protocols. Gertner et al. [2] investigated women
after 1 week on a standardized diet of 800 mg calcium
per day. In addition, in the studies performed by Kent et
al. [1] and Gertner et al. [2], no breakfast was reported
as given during the course of the calcium-tolerance test.
The breakfast given in this study, although small and low
in fat, protein, phytate, calcium and phosphorus content,
may have influenced the post-loading response due to a
delay in gastric emptying.
In conclusion, there were differences in pPTH, NcAMP
and p1,25(OH)2D and bone markers between pregnant,
lactating and NPNL Gambian women adapted to a low
calcium intake similar to those described in Western women.
There was no evidence of pregnancy-induced absorptive
hypercalciuria as observed in Western women with higher
calcium intakes. The response to calcium loading indicates
that there may be no differences in renal and intestinal
calcium economy between pregnant, lactating and non-
pregnant, non-lactating women, potentially due to a high
degree of calcium conservation associated with low intakes.
Larger studies designed to assess calcium economy in the
intestine and kidney are required to confirm these findings.
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Fig. 3 Response of plasma markers of bone resorption (beta C-termi-
nal cross-linked telopeptide of type 1 collagen (pβCTX; a) and forma-
tion (bone-specific alkaline phosphatase (BALP; b) and osteocalcin
(OC; c)) to calcium loading in pregnant, lactating and non-pregnant
and non-lactating women. Data are presented as mean + SE. No
significant between-group differences in the change of any of these
analytes were found. See Fig. 1 for further explanation of symbols used
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